|
Dear Colleagues and Friends, I write this farewell message and President’s Report with pride, gratitude, and renewed confidence in the future of our Society - ALPHA Scientists in Reproductive Medicine. It has been my privilege to serve on the Executive Board of ALPHA since 2017, and as President from 2022 to 2026. Over these years, my belief in the importance of this international Society and the people who have sustained it has only grown. ALPHA was founded 32 years ago by a small group of scientists with a clear and ambitious mission to bring together, support and represent embryologists in the young but rapidly advancing field of assisted reproduction. That mission inspired the many colleagues who joined in and carried the torch for ALPHA over the ensuing years, including our past presidents (now honorary members) and the many Board members and others whose dedication helped keep ALPHA active. When the torch was passed to me in 2022, after serving as Vice President to Sharon Mortimer, and given the privilege of having Alison Campbell as my Vice President, it was clear to us that our Society required a stronger infrastructure to continue to realise its goals and ambitions. Together with the Board, we set this as our immediate goal. We introduced a new logo for the Society, inspired by the early embryo, and reflecting how distinct individual parts, through connection, become something entirely new with a meaning and potential beyond each part alone. We then commissioned a new website, with aesthetics and content that better reflect the Society’s identity. Using historical records and recollections, we are now working to present as accurate a historical portrait of the Society as possible. We appointed a new secretariat, Profile Productions, whose professional support has assisted the leadership in advancing several key infrastructure priorities. We have: modernised and streamlined membership processes, fostering steady membership growth; improved financial transparency through the transfer of our accounts to the UK and renewed registration with Companies House, ensuring compliance with all relevant regulations; carefully reviewed our Constitution, Rules and Bylaws, implementing updates while preserving the original document; and further clarified the roles and responsibilities of officers and Executive Board members to strengthen effective governance. We created the non-Board position of ALPHA Ambassador, to provide an opportunity to our members to contribute to the Society through advocacy, community engagement, member recruitment, and public relations. A first project for our first ambassadors was to revive the ALPHA newsletter, which was published in paper form circa 1995 - 2008, to offer news of interest, commentary, interviews, surveys, and more. The new newsletter is called SCOPE. As a result of these efforts, ALPHA is now better positioned than ever to think strategically and to pursue a meaningful five-year vision centered not only on our members, but on all laboratory professionals working in reproductive medicine around the world. At the same time, we continued to advance the educational and scientific mission of the Society. ALPHA 2024 in Lisbon was a memorable and highly successful conference, while ALPHA 2026 in Dubrovnik set new records in attendance and sponsorship and has received exceptionally positive feedback from the delegates that represented some 56 different countries and 6 continents. The essence of ALPHA was reflected in our international delegates and speakers. In collaboration with ESHRE SIG Embryology, we updated the Istanbul Consensus (2011), producing what we hope will remain an important reference for years to come. We have also initiated another collaboration to update the Vienna Consensus on laboratory KPIs (2017) and the cryopreservation KPI Consensus (2012), both valuable resources now due for revision. We developed the Cairo Consensus on future-proofing the laboratory, offering practical guidance for laboratories worldwide to build resilience and ensure continuity in times of disruption. The proceedings of another Cairo Consensus meeting on clinical factors affecting embryo development and competence are now being prepared for publication. Our well-received debut film, Global Voices in Embryology, featured practitioners from many countries as they shared their perspectives, hopes and challenges, and revealed their deep commitment to their profession. Our partnership with RBMO has continued to flourish, and we were honored to receive the RGE Runner-Up Prize for our collaboration with the International IVF Initiative (I3) on a first-time effort to bring attention to sustainability in the IVF laboratory. These achievements were made possible by dedicated Board members, officers, collaborators, and by the many members and supporters who gave their time, expertise and trust so generously. I offer my sincere thanks to you. Serving ALPHA has been one of the great privileges of my professional life. I now pass the torch with complete confidence to Alison Campbell, whom I admire and respect deeply. It has been an honour to work alongside Alison as Vice President and a great pleasure to see that partnership grow into a lasting friendship. I am equally delighted that Laura Rienzi now assumes the role of Vice President, bringing exceptional experience, insight and vision to the leadership of our Society. Alison and Laura will shape an exciting new chapter for ALPHA. I leave office with gratitude for the trust placed in me, pride in what we have achieved together, and every confidence that the Society’s best years still lie ahead. With warm regards, Mina Alikani President (2022 –2026) ALPHA Scientists in Reproductive Medicine
|